7-97856689-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001673.5(ASNS):c.1030+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.00000138 in 1,444,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001673.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001673.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ASNS | NM_001673.5 | MANE Select | c.1030+1G>A | splice_donor intron | N/A | NP_001664.3 | |||
| ASNS | NM_001352496.2 | c.1030+1G>A | splice_donor intron | N/A | NP_001339425.1 | ||||
| ASNS | NM_133436.3 | c.1030+1G>A | splice_donor intron | N/A | NP_597680.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ASNS | ENST00000394308.8 | TSL:1 MANE Select | c.1030+1G>A | splice_donor intron | N/A | ENSP00000377845.3 | |||
| ASNS | ENST00000175506.8 | TSL:1 | c.1030+1G>A | splice_donor intron | N/A | ENSP00000175506.4 | |||
| ASNS | ENST00000394309.7 | TSL:2 | c.1030+1G>A | splice_donor intron | N/A | ENSP00000377846.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000415 AC: 1AN: 241002 AF XY: 0.00000768 show subpopulations
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1444796Hom.: 0 Cov.: 30 AF XY: 0.00000279 AC XY: 2AN XY: 718058 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome Pathogenic:2
not provided Pathogenic:1
This sequence change affects a donor splice site in intron 8 of the ASNS gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ASNS are known to be pathogenic (PMID: 27422383, 30057589). This variant is present in population databases (rs780288372, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with ASNS-related conditions. ClinVar contains an entry for this variant (Variation ID: 434401). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at